Guardant Health
GH
#2583
Rank
A$8.33 B
Marketcap
$67.55
Share price
5.05%
Change (1 day)
135.62%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$2.57 Billion

According to Guardant Health 's latest financial reports the company's total liabilities are A$2.57 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$2.61 B9.37%
2023-12-31A$2.38 B4.91%
2022-12-31A$2.27 B5.87%
2021-12-31A$2.15 B80.53%
2020-12-31A$1.19 B628.31%
2019-12-31A$0.16 B84.55%
2018-12-31A$88.64 M101.59%
2017-12-31A$43.97 M-14.02%
2016-12-31A$51.14 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$0.73 B-71.37%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.19 B-14.78%๐Ÿ‡บ๐Ÿ‡ธ USA